Dörte Hamann

9.1k citations

79 papers · 6.9k indexed · 2 hit papers · h-index 38

Virology top 0.2%
- HIV Research and Treatment 21
Immunology top 0.5%
- Immune Cell Function and Interaction 20
- T-cell and B-cell Immunology 19
- Immunodeficiency and Autoimmune Disorders 7
Infectious Diseases top 1%
- HIV/AIDS Research and Interventions 11
Rheumatology top 1%
- Systemic Lupus Erythematosus Research 14
- Rheumatoid Arthritis Research and Therapies 10
Immunology and Allergy top 2%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 14

Co-authors: Frank Miedema René A. W. van Lier Mette D. Hazenberg Sigrid A. Otto Berend Hooibrink Paul A. Baars Michèl R. Klein M.H.G. Rep
Cited by: Virology Immunology Infectious Diseases
Journals: AIDS (7 papers)Annals of the Rheumatic Diseases (6 papers)Blood (4 papers)
Partner nations: Netherlands Ethiopia United States

In The Last Decade

Dörte Hamann

78 papers receiving 6.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Dörte Hamann

Since Specialization

Citations

This map shows the geographic impact of Dörte Hamann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dörte Hamann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dörte Hamann more than expected).

Fields of papers citing papers by Dörte Hamann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dörte Hamann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dörte Hamann. The network helps show where Dörte Hamann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dörte Hamann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dörte Hamann Line = papers co-authored together Dörte Hamann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study Journal of Autoimmunity ·D. Doering,Ester M. van Leeuwen,Arab Kheradmand Ali,Anneke J. van der Kooi,Kyra A. Gelderman,Dörte Hamann,Ellen G. van Lochem,Bob Meek,Renate G. van der Molen,Riccardo Stolica,Henny G. Otten,Marco W.J. Schreurs,Joost Raaphorst	2023	2
2	The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults Multiple Sclerosis Journal ·Casper L. de Mol,Ang Ji,Goodwill Kudakwashe Chademana,Bae Jeong Sang,Dylan Bouëtard,R. F. Neuteboom,Dörte Hamann,RQ Hintzen	2019	146
3	International Consensus on ANA Patterns (ICAP) : inbedding in het Nederlandse taalgebied Research Publications (Maastricht University) ·Jan Damoiseaux,Xavier Bossuyt,Sylvia Broeders,Dörte Hamann,Karina de Leeuw,Maarten Limper,Henny G. Otten,Caroline Roozendaal,Sofie Schouwers,信雄芹澤,Brock Millman,Paul Van Daele,Renate van der Molen,Jung Soo Ok,A. Chudnovsky,Carolien Bonroy	2018	1
4	ELISA to measure neutralizing capacity of anti-C1-inhibitor antibodies in plasma of angioedema patients Journal of Immunological Methods ·Ruchira Engel,Irma Rensink,Dorina Roem,Mieke C. Brouwer,Rasil Alotaibi,I. A. Portianskaya,Sacha Zeerleder,Diana Wouters,Dörte Hamann	2015	9
5	ANTI-CARBAMYLATED PROTEIN ANTIBODIES (ANTI-CARP) PRECEDE THE ONSET OF RHEUMATOID ARTHRITIS Annals of the Rheumatic Diseases ·Jinxia Shi,Γεώργιος Πασαγιάννης,Nivine Levarht,T. Huizinga,Dörte Hamann,D. van Schaardenburg,René E. M. Toes,Leendert A. Trouw	2013	1
6	922 INCREASED CANCER RISK IN A LARGE POPULATION-BASED COHORT OF PATIENTS WITH PRIMARY BILIARY CIRRHOSIS: FOLLOW-UP FOR UP TO 36 YEARS Journal of Hepatology ·Kirsten Boonstra,P.H.G.M. Stadhouders,Hans A.R.E. Tuynman,Alexander C. Poen,Carin M.J. van Nieuwkerk,Ellen M. Witteman,Dörte Hamann,Ben Witteman,Ulrich Beuers,Cyriel Y. Ponsioen	2013	4
7	Monoclonal anti-citrullinated protein antibodies selected on citrullinated fibrinogen have distinct targets with different cross-reactivity patterns Lara D. Veeken ·Lotte A van de Stadt,Pauline A. van Schouwenburg,Susanne Bryde,Simone Kruithof,Dirkjan van Schaardenburg,Dörte Hamann,Gertjan Wolbink,Theo Rispens	2012	36
8	Autoantibody Standardization in the Netherlands Annals of the New York Academy of Sciences ·Jan Damoiseaux,Jan Willem Cohen Tervaert,Ronald H. W. M. Derksen,Dörte Hamann,Herbert Hooijkaas,Ina S. Klasen,Cees G. M. Kallenberg,Pieter C. Limburg,Ruud J.T. Smeenk	2009	12
9	Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study Arthritis Research & Therapy ·Jennie Ursum,Markus M. J. Nielen,Dirkjan van Schaardenburg,A. R. van der Horst,Rob J. van de Stadt,Ben A. C. Dijkmans,Dörte Hamann	2008	74
10	Determinants of CD4 Counts Among HIV-Negative Ethiopians: Role of Body Mass Index, Gender, Cigarette Smoking, Khat (Catha Edulis) Chewing, and Possibly Altitude? Journal of Clinical Immunology ·Cherinet Abuye,Aster Tsegaye,C.E. West,Pieter Versloot,Eduard J. Sanders,Dawit Wolday,Dörte Hamann,Tobias F. Rinke de Wit,Arnaud Fontanet	2005	26
11	Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis Annals of the Rheumatic Diseases ·M. Nielen,A. R. van der Horst,D. van Schaardenburg,Irene E. van der Horst‐Bruinsma,R J van de Stadt,L Aarden,B.A.C. Dijkmans,Dörte Hamann	2005	147
12	T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation Journal of Molecular Medicine ·Mette D. Hazenberg,Martie C. M. Verschuren,Dörte Hamann,Frank Miedema,Jacques J. M. van Dongen	2001	241
13	No Difference in in Vitro Susceptibility to HIV Type 1 between High-Risk HIV-Negative Ethiopian Commercial Sex Workers and Low-Risk Control Subjects AIDS Research and Human Retroviruses ·Tsehaynesh Messele,Tobias F. Rinke de Wit,Margreet Brouwer,ياسمينة بن يوسف,Burçin Elaziz,Arnaud Fontanet,Hanneke Schuitemaker,Dörte Hamann	2001	18
14	Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection Nature Medicine ·Mette D. Hazenberg,Sigrid A. Otto,J. W. T. Cohen Stuart,Martie C. M. Verschuren,Jan C.C. Borleffs,Charles A. Boucher,Roel A. Coutinho,Joep M. A. Lange,Tobias F. Rinke de Wit,Aster Tsegaye,Jacques J. M. van Dongen,Dörte Hamann,Rob J. de Boer,Frank Miedema	2000	321
15	Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy AIDS ·Nadine G. Pakker,黄启宇,Marijke Roos,Sigrid A. Otto,David B. Hall,Ferdinand W.N.M. Wit,Dörte Hamann,D. N. Biswas,Frans A.P. Claessen,Robert H. Kauffmann,Peter P. Koopmans,Frank P. Kroon,Chris H.H. ten Napel,Herman G. Sprenger,Hugo M. Weigel,Julio Montaner,Joep M. A. Lange,Peter Reiss,P T Schellekens,Frank Miedema	1999	87
16	Evidence that human CD8+CD45RA+CD27– cells are induced by antigen and evolve through extensive rounds of division International Immunology ·Dörte Hamann,Stefan Kostense,Katja C. Wolthers,Sigrid A. Otto,Paul A. Baars,Viviane de Moura,René A. W. van Lier	1999	150
17	Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. Journal of Clinical Investigation ·Taco W. Kuijpers,René A. W. van Lier,Dörte Hamann,Martin de Boer,Molthan Agnes,Ron S. Weening,AJ Verhoeven,Dirk Roos	1997	166
18	Der Einfluß der Reduktion der Bestrahlungsdosis auf die Inzidenz der radiogenen Pneumonitis, Lungenfibrose und Perikarditis nach Mediastinalbestrahlung bei der Behandlung der Lymphogranulomatose Strahlentherapie und Onkologie ·英明森,Ralph Mücke,Anthony Jebrayel,Hellen Knauerhase,S.N. Kovalenko,Dörte Hamann,Günther Kundt,Eduardo Fernando Uliana Barboza	1997	1
19	Conformational Changes in CD45 upon Monoclonal Antibody Crosslinking Hybridoma ·Dörte Hamann,Wolfram Eichler,H.H. Fiebig,René A. W. van Lier	1996	3
20	Characterization of an Early Activation‐Dependent Antigen on Lymphocytes Defined by the Monoclonal Antibody BL‐Ac(F2) Scandinavian Journal of Immunology ·Wd. Eichler,Gabriela Aust,Dörte Hamann	1994	61

About Dörte Hamann

Dörte Hamann is a scholar working on Virology, Immunology, Rheumatology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 79 papers that have together received 6.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (21 papers), Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (19 papers), Systemic Lupus Erythematosus Research (14 papers), Monoclonal and Polyclonal Antibodies Research (14 papers), HIV/AIDS Research and Interventions (11 papers), Rheumatoid Arthritis Research and Therapies (10 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). The work is most often cited by research in Virology (2.2k citations), Immunology (3.8k citations), Infectious Diseases (1.2k citations), Rheumatology (913 citations) and Immunology and Allergy (272 citations). Dörte Hamann has collaborated with scholars based in Netherlands, Ethiopia and United States. Frequent co-authors include Frank Miedema, René A. W. van Lier, Mette D. Hazenberg, Sigrid A. Otto, Berend Hooibrink, Paul A. Baars, Michèl R. Klein, M.H.G. Rep, Marijke Roos and Rob J. de Boer. Their work appears in journals such as AIDS, Annals of the Rheumatic Diseases, Blood, Clinical Chemistry and Laboratory Medicine (CCLM) and Multiple Sclerosis Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact